MENU

NUVL Nuvalent Forecast, Technical & Fundamental Analysis

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more

NUVL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NUVL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NUVL is expected to report earnings to rise 1.44% to -140 cents per share on August 06

Nuvalent NUVL Stock Earnings Reports
Q2'26
Est.
$-1.41
Q1'26
Missed
by $0.04
Q4'25
Missed
by $0.10
Q3'25
Missed
by $0.34
Q2'25
Missed
by $0.17
The last earnings report on May 07 showed earnings per share of -138 cents, missing the estimate of -135 cents. With 339.09K shares outstanding, the current market capitalization sits at 9.79B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
228
Web
https://www.nuvalent.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MUSA606.8131.17
+5.41%
Murphy USA
ENTA14.26N/A
N/A
Enanta Pharmaceuticals
UPXI0.83N/A
N/A
Upexi Inc
INTA28.18N/A
N/A
Intapp
QSEAU10.70N/A
N/A
Quartzsea Acquisition Corp

NUVL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with MLTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
N/A
MLTX - NUVL
49%
Loosely correlated
N/A
XNCR - NUVL
43%
Loosely correlated
N/A
PCVX - NUVL
41%
Loosely correlated
N/A
PTGX - NUVL
40%
Loosely correlated
N/A
ARQT - NUVL
39%
Loosely correlated
N/A
More
Nuvalent (NUVL) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com